Enantiomer‐Specific Cardiovascular Effects of the Ketone Body 3‐Hydroxybutyrate

Author:

Gopalasingam Nigopan123ORCID,Moeslund Niels24ORCID,Christensen Kristian Hylleberg12,Berg‐Hansen Kristoffer12ORCID,Seefeldt Jacob12ORCID,Homilius Casper5ORCID,Nielsen Erik Nguyen6ORCID,Dollerup Mie Ringgaard6ORCID,Alstrup Olsen Aage K.26ORCID,Johannsen Mogens7ORCID,Boedtkjer Ebbe5ORCID,Møller Niels8ORCID,Eiskjær Hans1ORCID,Gormsen Lars Christian6ORCID,Nielsen Roni1ORCID,Wiggers Henrik1ORCID

Affiliation:

1. Department of Cardiology Aarhus University Hospital Aarhus Denmark

2. Department of Clinical Medicine Aarhus University Aarhus Denmark

3. Department of Cardiology Gødstrup Hospital Herning Denmark

4. Department of Heart, Lung and Vascular Surgery Aarhus University Hospital Aarhus Denmark

5. Department of Biomedicine Aarhus University Aarhus Denmark

6. Department of Nuclear Medicine and PET Aarhus University Hospital Aarhus Denmark

7. Department of Forensic Medicine Aarhus University Aarhus Denmark

8. Department of Endocrinology and Metabolism Aarhus University Aarhus Denmark

Abstract

Background The ketone body 3‐hydroxybutyrate (3‐OHB) increases cardiac output (CO) by 35% to 40% in healthy people and people with heart failure. The mechanisms underlying the effects of 3‐OHB on myocardial contractility and loading conditions as well as the cardiovascular effects of its enantiomeric forms, D‐3‐OHB and L‐3‐OHB, remain undetermined. Methods and Results Three groups of 8 pigs each underwent a randomized, crossover study. The groups received 3‐hour infusions of either D/L‐3‐OHB (racemic mixture), 100% L‐3‐OHB, 100% D‐3‐OHB, versus an isovolumic control. The animals were monitored with pulmonary artery catheter, left ventricle pressure‐volume catheter, and arterial and coronary sinus blood samples. Myocardial biopsies were evaluated with high‐resolution respirometry, coronary arteries with isometric myography, and myocardial kinetics with D‐[ 11 C]3‐OHB and L‐[ 11 C]3‐OHB positron emission tomography. All three 3‐OHB infusions increased 3‐OHB levels ( P <0.001). D/L‐3‐OHB and L‐3‐OHB increased CO by 2.7 L/min ( P <0.003). D‐3‐OHB increased CO nonsignificantly ( P =0.2). Circulating 3‐OHB levels correlated with CO for both enantiomers ( P <0.001). The CO increase was mediated through arterial elastance (afterload) reduction, whereas contractility and preload were unchanged. Ex vivo, D‐ and L‐3‐OHB dilated coronary arteries equally. The mitochondrial respiratory capacity remained unaffected. The myocardial 3‐OHB extraction increased only during the D‐ and D/L‐3‐OHB infusions. D‐[ 11 C]3‐OHB showed rapid cardiac uptake and metabolism, whereas L‐[ 11 C]3‐OHB demonstrated much slower pharmacokinetics. Conclusions 3‐OHB increased CO by reducing afterload. L‐3‐OHB exerted a stronger hemodynamic response than D‐3‐OHB due to higher circulating 3‐OHB levels. There was a dissocitation between the myocardial metabolism and hemodynamic effects of the enantiomers, highlighting L‐3‐OHB as a potent cardiovascular agent with strong hemodynamic effects.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3